A review of potential bluetongue virus vaccine strategies

Christie Mayo, Justin Lee, Jennifer Kopanke, Nigel J Maclachlan

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Bluetongue (BT) is an economically important, non-zoonotic arboviral disease of certain wild and domestic species of cloven-hooved ungulates. Bluetongue virus (BTV) is the causative agent and the occurrence of BTV infection is distinctly seasonal in temperate regions of the world, and dependent on the presence of vector biting midges (e.g. Culicoides sonorensis in much of North America). In recent years, severe outbreaks have occurred throughout Europe and BTV is endemic in most tropical and temperate regions of the world. Several vaccines have been licensed for commercial use, including modified live (live-attenuated) and inactivated products, and this review summarizes recent strategies developed for BTV vaccines with emphasis on technologies suitable for differentiating naturally infected from vaccinated animals. The goal of this review is to evaluate realistic vaccine strategies that might be utilized to control or prevent future outbreaks of BT.

Original languageEnglish (US)
JournalVeterinary Microbiology
DOIs
StateAccepted/In press - Oct 11 2016

Fingerprint

Bluetongue virus
Vaccines
Bluetongue
Ceratopogonidae
vaccines
bluetongue
Disease Outbreaks
Culicoides sonorensis
Virus Diseases
North America
ungulates
Technology
infection
animals

Keywords

  • Bluetongue virus vaccine
  • Novel vaccine platforms

ASJC Scopus subject areas

  • Microbiology
  • veterinary(all)

Cite this

A review of potential bluetongue virus vaccine strategies. / Mayo, Christie; Lee, Justin; Kopanke, Jennifer; Maclachlan, Nigel J.

In: Veterinary Microbiology, 11.10.2016.

Research output: Contribution to journalArticle

@article{66f1894501414986b8daecfa330d3b4f,
title = "A review of potential bluetongue virus vaccine strategies",
abstract = "Bluetongue (BT) is an economically important, non-zoonotic arboviral disease of certain wild and domestic species of cloven-hooved ungulates. Bluetongue virus (BTV) is the causative agent and the occurrence of BTV infection is distinctly seasonal in temperate regions of the world, and dependent on the presence of vector biting midges (e.g. Culicoides sonorensis in much of North America). In recent years, severe outbreaks have occurred throughout Europe and BTV is endemic in most tropical and temperate regions of the world. Several vaccines have been licensed for commercial use, including modified live (live-attenuated) and inactivated products, and this review summarizes recent strategies developed for BTV vaccines with emphasis on technologies suitable for differentiating naturally infected from vaccinated animals. The goal of this review is to evaluate realistic vaccine strategies that might be utilized to control or prevent future outbreaks of BT.",
keywords = "Bluetongue virus vaccine, Novel vaccine platforms",
author = "Christie Mayo and Justin Lee and Jennifer Kopanke and Maclachlan, {Nigel J}",
year = "2016",
month = "10",
day = "11",
doi = "10.1016/j.vetmic.2017.03.015",
language = "English (US)",
journal = "Veterinary Microbiology",
issn = "0378-1135",
publisher = "Elsevier",

}

TY - JOUR

T1 - A review of potential bluetongue virus vaccine strategies

AU - Mayo, Christie

AU - Lee, Justin

AU - Kopanke, Jennifer

AU - Maclachlan, Nigel J

PY - 2016/10/11

Y1 - 2016/10/11

N2 - Bluetongue (BT) is an economically important, non-zoonotic arboviral disease of certain wild and domestic species of cloven-hooved ungulates. Bluetongue virus (BTV) is the causative agent and the occurrence of BTV infection is distinctly seasonal in temperate regions of the world, and dependent on the presence of vector biting midges (e.g. Culicoides sonorensis in much of North America). In recent years, severe outbreaks have occurred throughout Europe and BTV is endemic in most tropical and temperate regions of the world. Several vaccines have been licensed for commercial use, including modified live (live-attenuated) and inactivated products, and this review summarizes recent strategies developed for BTV vaccines with emphasis on technologies suitable for differentiating naturally infected from vaccinated animals. The goal of this review is to evaluate realistic vaccine strategies that might be utilized to control or prevent future outbreaks of BT.

AB - Bluetongue (BT) is an economically important, non-zoonotic arboviral disease of certain wild and domestic species of cloven-hooved ungulates. Bluetongue virus (BTV) is the causative agent and the occurrence of BTV infection is distinctly seasonal in temperate regions of the world, and dependent on the presence of vector biting midges (e.g. Culicoides sonorensis in much of North America). In recent years, severe outbreaks have occurred throughout Europe and BTV is endemic in most tropical and temperate regions of the world. Several vaccines have been licensed for commercial use, including modified live (live-attenuated) and inactivated products, and this review summarizes recent strategies developed for BTV vaccines with emphasis on technologies suitable for differentiating naturally infected from vaccinated animals. The goal of this review is to evaluate realistic vaccine strategies that might be utilized to control or prevent future outbreaks of BT.

KW - Bluetongue virus vaccine

KW - Novel vaccine platforms

UR - http://www.scopus.com/inward/record.url?scp=85016434067&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016434067&partnerID=8YFLogxK

U2 - 10.1016/j.vetmic.2017.03.015

DO - 10.1016/j.vetmic.2017.03.015

M3 - Article

C2 - 28377132

AN - SCOPUS:85016434067

JO - Veterinary Microbiology

JF - Veterinary Microbiology

SN - 0378-1135

ER -